Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Researchers Assess Use of Drug-Susceptible Parasites to Fight Drug Resistance

November 30, 2015 8:00 am | by University of Georgia | News | Comments

Researchers have developed a model for evaluating a potential new strategy in the fight against drug-resistant diseases. Read more...

New Gene Map Reveals Cancer's Achilles Heel

November 30, 2015 7:45 am | by University of Toronto | News | Comments

Scientists have mapped out the genes that keep our cells alive, creating a long-awaited foothold for understanding how our genome works and which genes are crucial in disease like cancer. Read more...


GSK in China: Escaping The Shadow of a Scandal

November 30, 2015 7:30 am | by Adam Jourdan and Ben Hirschler, Reuters | News | Comments

GlaxoSmithKline Plc has cut 40 percent of its sales reps in China and axed some units as it eyes a return to growth in 2016. Read more...


Antibody Drug Compounds, Immunotherapy to Treat Breast Cancer

November 30, 2015 7:15 am | by University of Basel | News | Comments

The researchers demonstrate that the use of specific cytotoxic substances can also have a beneficial effect on the body's immune system. Read more...


EU Approves Amgen's Blincyto to Treat Rare Form of ALL

November 30, 2015 7:00 am | News | Comments

ALL is a rare and rapidly progressing cancer of the blood and bone marrow. Read more...


Drug Discovery Spotlight: Pfizer-Allergan Merger; FDA Approvals; and More

November 27, 2015 10:03 am | by Stephanie Guzowski, Editor | News | Comments

Welcome to Drug Discovery Spotlight, where we’ve rounded up this week’s trending headlines. Read more..


Researchers Urge Caution in Prescribing Commonly Used Drug to Treat ADHD

November 25, 2015 11:29 am | News | Comments

Authors of new Cochrane Review remain uncertain about effect of widely used medicine on ADHD symptoms, despite large amount of research. Some evidence of increased sleeplessness and loss of appetite leads researchers to encourage more caution in use of methylphenidate. Read more...


Research Team Finds That Protein Motions Regulate HIV Infectivity

November 25, 2015 11:20 am | by University of Delaware | News | Comments

Nearly 37 million people worldwide are living with HIV. When the virus destroys so many immune cells that the body can't fight off infection, AIDS will develop. The disease took the lives of more than a million people last year. Read more...


Drug Combination for Advanced Prostate Cancer

November 25, 2015 11:10 am | by University of Montreal Hospital Research Centre (CRCHUM) | News | Comments

A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide. Read more...


Researchers Study Alzheimer’s Disease in People with Down Syndrome

November 25, 2015 11:02 am | by Columbia University | News | Comments

The risk of Alzheimer’s disease—the most common cause of dementia—increases as a person ages. But the risk of Alzheimer’s is increased dramatically for adults with Down syndrome. Read more...


Human Cell Cloning Method Dramatically Improved, says Study

November 25, 2015 10:55 am | by Cynthia Fox, Science Editor | Articles | Comments

Upping the stakes in the enduring competition between pluripotent/embryonic stem cells made via the iPSC method, and via cloning, a Harvard University group has reported dramatically improving the efficiency of cloning. Read more...


FDA Panel: BioMarin Muscular Dystrophy Drug Trials Didn’t Prove Effectiveness

November 25, 2015 10:15 am | by Thomas M. Burton, The Wall Street Journal | News | Comments

A Food and Drug Administration advisory panel concluded that a new drug from BioMarin Pharmaceutical Inc. hasn’t been proven to effectively treat the fatal disease called Duchenne muscular dystrophy, saying studies simply didn’t prove the medicine worked in most patients. Read more...


Turing Pharmaceuticals to Retain Daraprim List Price, Offer Discounts to Hospitals

November 25, 2015 9:59 am | by Matthew Dennis, FirstWordPharma | News | Comments

Turing Pharmaceuticals announced that it will retain the current list price of Daraprim (pyrimethamine), whilst offering reductions of up to 50 percent for hospitals. Turing has faced recent criticism after the cost of the toxoplasmosis therapy jumped from $13.50 a tablet to $750, with CEO Martin Shkreli suggesting that the company would address the issue. Read more...


Allergan, Rugen Therapeutics To Collaborate on Treatments for Autism, OCD

November 25, 2015 9:41 am | News | Comments

Allergan plc, a leading global pharmaceutical company, and Rugen Therapeutics, a start-up  biotechnology company focused on the development of novel treatments for unmet CNS disorders and funded by the F-Prime Biomedical Research Initiative (FBRI), today announced that they have entered into an exclusive collaboration. Read more...


Immune-disorder Treatment in Mice Holds Potential for Multiple Sclerosis Patients

November 25, 2015 9:27 am | by University of Florida | News | Comments

A University of Florida Health researcher has found a simple, rapid way to treat an immune-related disorder in mice, an approach that could eventually help multiple sclerosis patients after further research. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.